IDEXX LABORATORIES INC /DE — Director's Dealing 2021

Feb 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-02-12

Reporting Person: Vandebroek Sophie V. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-12	Common Stock	M	3046	$160.28	Acquired	6367	Direct
2021-02-12	Common Stock	S	3046	$538.20	Disposed	3321	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-12	Non-Qualified Stock Option (right-to-buy)	$160.28	M	3046	Disposed	2027-05-02	Common Stock (3046)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6000	Indirect

Footnotes

F1: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable on May 3, 2018.

F2: Not applicable.